KIMBERLY MCGOWEN: Open Payments
NPI 1952164527 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,453 in 110 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,086 · 2025 $3,453
Food & beverage: $2,648Travel & lodging: $670Education: $135
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 11 | $1,019 |
| ABBVIE INC. | 36 | $646 |
| Ardelyx, Inc. | 13 | $279 |
| Janssen Biotech, Inc. | 10 | $267 |
| Lilly USA, LLC | 6 | $251 |
| Madrigal Pharmaceuticals | 5 | $217 |
| Novo Nordisk Inc | 3 | $153 |
| GENZYME CORPORATION | 1 | $124 |
| Intercept Pharmaceuticals, Inc. | 2 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $103 |
Products named: INTERSTIM, IBSRELA, TREMFYA, OMVOH, REZDIFFRA, LINZESS, SKYRIZI, RINVOQ.
Industry payments across FL — which companies pay providers there.
